Caribou Biosciences, Inc. (CRBU) Tops Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts CRBU Hot Sheet
Join SI Premium – FREE
Caribou Biosciences, Inc. (NASDAQ: CRBU) reported Q1 EPS of ($0.43), $0.02 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $2.35 million versus the consensus estimate of $1.5 million.
For earnings history and earnings-related data on Caribou Biosciences, Inc. (CRBU) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
- SpaceX files for 555.56M share IPO at $135/sh
- Broadcom (AVGO) Tops Q2 EPS by 5c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
